- Trials with a EudraCT protocol (44,346)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
44,346 result(s) found.
Displaying page 519 of 2,218.
EudraCT Number: 2008-006749-18 | Sponsor Protocol Number: HE06-001-C P4 | Start Date*: 2009-06-26 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Efficacy and safety of 6 % hydroxyethyl starch 130/0.4 (Voluven®) vs. 5% HSA in volume replacement therapy during elective open-heart surgery in paediatric patients | |||||||||||||
Medical condition: Volume replacement therapy during elective open-heart surgery in paediatric patients | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005497-28 | Sponsor Protocol Number: PedMic | Start Date*: 2013-09-27 |
Sponsor Name:Erasmus MC - Sophia | ||
Full Title: Pediatric Microdosing: elucidating age-related changes in oral absorption | ||
Medical condition: Age-related changes in intestinal drug metabolism in children | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005514-10 | Sponsor Protocol Number: 0822-018 | Start Date*: 2012-03-14 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A 2nd Open-Label Extension for 5 Years to: The Placebo-Controlled 1st Extension to a Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduc... | |||||||||||||
Medical condition: Postmenopausal Osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: LT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004391-11 | Sponsor Protocol Number: RCC-DC-2011 | Start Date*: 2012-02-08 |
Sponsor Name:Masaryk University | ||
Full Title: Treatment of metastatic renal cell carcinoma using interleukin-12 secreting dendritic cells. Phase I/II clinical trial. | ||
Medical condition: Metatastic renal cell carcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001642-14 | Sponsor Protocol Number: n/a | Start Date*: 2011-07-11 |
Sponsor Name:University of Surrey | ||
Full Title: The effects of subcutaneous insulin detemir on glucose flux, pharmacokinetics and brain function in type one diabetes | ||
Medical condition: Type 1 diabetes mellitus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004755-39 | Sponsor Protocol Number: ML25710 | Start Date*: 2012-08-17 | |||||||||||
Sponsor Name:Genentech, Inc. | |||||||||||||
Full Title: A randomized phase II study of Bevacizumab/mFOLFOX6 vs. Bevacizumab/FOLFIRI with biomarker stratification in patients with previously untreated metastatic colorectal cancer | |||||||||||||
Medical condition: Metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) EE (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015296-26 | Sponsor Protocol Number: SCLC | Start Date*: 2009-12-09 | |||||||||||
Sponsor Name:AZIENDA USL 6 LIVORNO ZONA LIVORNESE | |||||||||||||
Full Title: MULTICENTRIC PROSPECTIVE DOSE-FINDING AND PHASE II STUDY WITH ORAL TOPOTECAN IN ADVANCED SMALL-CELL LUNG CANCER (SCLC) PATIENTS RECURRENT AFTER A FIRST LINE THERAPY | |||||||||||||
Medical condition: patients with ADVANCED SMALL-CELL LUNG CANCER (SCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015383-33 | Sponsor Protocol Number: Eto-Dic-01 | Start Date*: 2010-08-30 | |||||||||||
Sponsor Name:Freistaat Bayern, vertreten durch die Universität Regensburg | |||||||||||||
Full Title: Die perioperative Anwendung von Etoricoxib verglichen mit Diclofenac bei Patienten nach Implantation einer Hüftgelenkstotalendoprothese, prospektive, doppelt blinde Phase IIIb Studie | |||||||||||||
Medical condition: In this clinical trial we will investigate patients who suffer from primary or secondary coxarthrosis where an implantation of a total hip joint endoprosthesis is indicated. It will be analyzed whe... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000612-26 | Sponsor Protocol Number: FINTOURPARK | Start Date*: 2011-09-19 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI | |||||||||||||
Full Title: Open-label study on the use of Finasteride in prolonged treatment (4 years) of tics in Tourette's disease and Parkinson's disease in the pounding | |||||||||||||
Medical condition: Syndrome Gilles de la Tourette's disease Parkinosn Pounding | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000626-29 | Sponsor Protocol Number: KS001 | Start Date*: 2011-12-13 |
Sponsor Name:QUEEN MARY UNIVERSITY OF LONDON | ||
Full Title: Keloid Scars: A randomised clinical and laboratory based study on the treatment and differentiation factors of the local disease | ||
Medical condition: Keloid scarring | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-000631-92 | Sponsor Protocol Number: CQGE031A2208 | Start Date*: 2011-12-07 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A phase II, randomized, double-blind, placebo controlled, parallel design, dose ranging, multi-center trial of four levels of exposure of QGE031 s.c. for 16 weeks in subjects aged 18 years and olde... | |||||||||||||
Medical condition: Peanut allergy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) GB (Prematurely Ended) GR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004201-25 | Sponsor Protocol Number: 1B | Start Date*: 2011-11-30 |
Sponsor Name:Erasmus MC | ||
Full Title: The BOKITO-1B Study: Tenofovir DF Bone and Kidney Toxicity. Pharmacology in HBV monoinfected patients. | ||
Medical condition: Chronic hepatitis B | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004217-17 | Sponsor Protocol Number: CICL670AUS32 | Start Date*: 2011-12-09 | |||||||||||
Sponsor Name:Novartis Pharmaceuticals Corporation | |||||||||||||
Full Title: A single-arm, open-label study of the Palatability and Tolerability of Exjade Taken with Meals, with Different Liquids or Crushed and Added to Food | |||||||||||||
Medical condition: transfusional hemosiderosis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006537-40 | Sponsor Protocol Number: VEG108838 | Start Date*: 2008-01-22 | |||||||||||
Sponsor Name:GlaxoSmithkline Research & Development Limited | |||||||||||||
Full Title: A Randomized, Multicenter, Phase III Study Comparing the Combination of Pazopanib and Lapatinib versus Lapatinib Monotherapy in Patients with ErbB2 over-expressing Inflammatory Breast Cancer | |||||||||||||
Medical condition: Relapsed or refractory inflammatory breast cancer with ErbB2 tumours. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) BE (Completed) DE (Prematurely Ended) GB (Completed) FR (Completed) ES (Completed) IT (Completed) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004718-40 | Sponsor Protocol Number: MELCOM-1 | Start Date*: 2011-07-18 | |||||||||||
Sponsor Name:AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE | |||||||||||||
Full Title: Activities of Metronidazole + Clotrimazole in the treatment and prophylaxis of recurrent vaginal infections recurrent Candida albicans and Candida albicans spp do not. | |||||||||||||
Medical condition: women with vaginal infections by Candida albicans and non-albicans Candida spp relapsing recurrent (≥ 4 events / year) in the acute phase of the disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000233-37 | Sponsor Protocol Number: IGFIMD | Start Date*: 2011-04-05 | |||||||||||
Sponsor Name:Stockholm Läns Landsting, Karolinska University Hospital | |||||||||||||
Full Title: Insulin-like Growth Factor (IGF-I) induced muscle glucose uptake and interstitial IGF-1 concentrations. Placebo controlled, crossover study of the effect of sc rhIGF-I(Increlex) administration on g... | |||||||||||||
Medical condition: Type 1 Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000257-23 | Sponsor Protocol Number: CTMK13 | Start Date*: 2011-06-14 | |||||||||||
Sponsor Name:Thornton & Ross Ltd | |||||||||||||
Full Title: A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin® Once liquid gel compared with Lyclear 1% permethrin crème rinse in the treatment of head lice | |||||||||||||
Medical condition: Head louse infestation (pediculosis capitis) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023208-29 | Sponsor Protocol Number: OXT-003 | Start Date*: 2011-08-02 |
Sponsor Name:Rheinische Friedrich-Wilhelms-University of Bonn | ||
Full Title: Effects of Oxytocin on opioide withdrawal symptoms | ||
Medical condition: Individuals with opioid dependence who are voluntary inpatients from detoxification unit are investigated. The opioid withdrawal symptome are observed. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003470-88 | Sponsor Protocol Number: 11-195 | Start Date*: 2012-07-30 | ||||||||||||||||
Sponsor Name:University Medical Center Utrecht, The Netherlands | ||||||||||||||||||
Full Title: Phenylephrine versus EPhedrine on cerebral Perfusion during carotid EndarteRectomy: PEPPER study | ||||||||||||||||||
Medical condition: Hypotension during carotid endarterectomy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003486-15 | Sponsor Protocol Number: SP0934 | Start Date*: 2012-06-13 | |||||||||||
Sponsor Name:UCB BIOSCIENCES GmbH | |||||||||||||
Full Title: A multi-center, randomized, double-blind, placebo-controlled, parallel group, polysomnography study to investigate safety and efficacy of the rotigotine transdermal patch in subjects with Restless ... | |||||||||||||
Medical condition: Restless Legs Syndrome in patients with End Stage Renal Disease (ESRD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) AT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
